PTC Therapeutics, Inc. (PTCT) Covered Calls

PTC Therapeutics, Inc. covered calls PTC Therapeutics Inc., is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

You can sell covered calls on PTC Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PTCT (prices last updated Wed 3:25 PM ET):

PTC Therapeutics, Inc. (PTCT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
45.31 -1.71 45.23 45.39 240K - 3.6
Covered Calls For PTC Therapeutics, Inc. (PTCT)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Dec 20 45 0.95 44.44 1.3% 158%
Jan 17 45 3.80 41.59 8.2% 96.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

PTC Therapeutics, Inc. is a biopharmaceutical company, which is focused on the discovery, development and commercialization of orally administered, small molecule therapeutics targeting an area of RNA biology. The company's preclinical and discovery programs are focused on the development of new treatments for multiple therapeutic areas, including neuromuscular disease, oncology and infectious disease. The company's lead product, candidate ataluren, is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. PTC Therapeutics was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.